Anti-bleeding med yanked after study shows higher death risk
(Newser) -
Bayer Pharmaceuticals will suspend the sale of Trasylol, a drug used to control bleeding during heart bypass surgery, after a clinical study found that the drug puts patients at increased risk of death, the
Washington Post reports. The FDA said sales of the drug would be halted at least until...
More »
